Head-to-head · WeighScore
Mirabel Meds vs Primary Clinic (Direct GLP)
The verdict
Primary Clinic (Direct GLP) takes it — 68.7/100 to 57.5/100.
Primary Clinic (Direct GLP) grades higher on WeighScore, our editorial score across cost value, dose & formulation, clinical oversight, labs & monitoring, fulfillment and contract terms. Primary Clinic (Direct GLP) is a Direct Primary Care membership rather than the usual direct-to-consumer GLP-1 marketplace.
We may earn a commission if you start care through some of these links, at no extra cost to you. It never moves the WeighScore, which is the weighted average of the six factors shown for every provider, and what we write about a provider is the same either way. See our disclosure.
Factor by factor
The same six graded dimensions, side by side. See the methodology.
The numbers
| Metric | Mirabel Meds | Primary Clinic (Direct GLP) |
|---|---|---|
| WeighScore | 57.5/100 | 68.7/100 |
| Grade | C | C |
| Scorecard rank | #397 | #144 |
| Semaglutide | Not disclosed | $65/mo (0.25 mg dose, promotional rate, compounded) |
| Tirzepatide | Not disclosed | $110/mo (2.5 mg dose, promotional rate, compounded) |
| Coverage | All 50 states | 10 states |
| Brand-name access | Compounded only | Compounded only |
| Oral / sublingual | Injection only | Injection only |
Graded #397 · C
Strengths
- LegitScript certified with board-certified Internal Medicine physician oversight
- Compounded semaglutide, tirzepatide, and GLP-1 microdose injection options
- White-glove concierge — direct provider messaging, no automated bots
- Cold-chain temperature-controlled delivery to all 50 states
- Monthly clinical reviews and dose adjustments included with every plan
Where it loses points
- Pricing not publicly disclosed — requires a consultation to receive a quote
- Compounded medications are not FDA-approved individual drugs
- No named pharmacy partner disclosed on public pages
- Labs not mentioned on any public page — baseline bloodwork protocol unknown
- Concierge positioning suggests premium pricing above market average
Graded #144 · C
Strengths
- Direct Primary Care model integrates GLP-1 with continuous primary care — unlike most direct-to-consumer platforms
- GLP-1 at wholesale cost with no markup — semaglutide from $65/mo, tirzepatide from $110/mo (members only)
- Unlimited primary care visits, direct text access, and same-day care bundled in the $89/mo membership
- Routine labs and thousands of medications included in membership — no surprise bills
- Per-dose pricing shown publicly for all 8 dose tiers of both semaglutide and tirzepatide
Where it loses points
- 10 states only (WA, NM, AZ, UT, FL, DC, KS, OK, VA, GA) — limited vs 50-state platforms
- Membership required to access wholesale pricing — $89/mo adds ~$1,068/yr in fixed cost
- 503A pharmacy partners not named
- LegitScript certification not mentioned on the site
- Medical director and corporate legal entity not disclosed
Also worth a look
Neither is our top-graded pick — CoreAge Rx leads the scorecard
Across all 499 providers, CoreAge Rx grades highest at 91.8/100 (A−). Top of the scorecard: flat transparent pricing, both molecules, nationwide — no teaser-rate games.
Pricing/verification reflect each provider's public disclosures at last grading; the WeighScore is our editorial judgment per the methodology. Prices change — confirm on each provider's site. Not medical advice; see our disclosure.